Aflac Incorporated reported third-quarter net earnings of $303 million, or $0.61 per diluted share, a significant decline from $1.6 billion in the prior year period due to net investment losses and a tax valuation allowance. Adjusted earnings were $1.2 billion, or $2.43 per diluted share, reflecting an 8.5% decrease driven by foreign currency headwinds and higher benefits in Japan. The company declared a fourth-quarter dividend of $0.61 per share, payable December 1 to shareholders of record on November 18, marking the 44th consecutive year of dividend increases. Aflac operates as a supplemental health insurance provider in the U.S. and Japan.
